[EldrickOnIce]

Originally Posted by Oling_Roachinen

So would you be in favour of monitoring anyone who has done bathsalts? I mean, at least they, for the most part, chose to take them. That's less unfair of a treatment to someone who had no choice for their actions...



Yes he does. And it's been considered for the last nine years, and continues to be considered. Just so does his eight years of more recent history where he has not had an incident.

And again, you've presented no evidence to suggest that he would go off his medication once monitoring ends. Of course it's a possibility, so is you developing schizophrenia and attacking an innocent person. Right now you're asking for 100% guarantee, that's not possible nor is it that basis of our Justice System...if it was everyone would be locked away so we couldn't do anything to anyone.

That he specifically will? No.
That statistically he will? Yes.

There is substantial evidence to suggest individuals suffering from this condition will be non compliant with medication. The US National Center for Biotechnology Information (NCBI) and PubMed link numerous studies that suggest compliance is a major problem, like this one.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782179/

Estimated non-adherence rates in schizophrenia are about 50%, widely ranging from 4% (observed in a study with depot neuroleptic drugs) to 72%[6]. Factors that might account for such variability include: definition of non-adherence and criteria used to determine it, methods for evaluating non-adherence and observation period[6]. Furthermore, adherence may vary during the patient’s evolution; it is usually good after hospital discharge and tends to decrease with time[1].

In a prospective study, one-third of patients admitted to hospital after their first psychotic episode of schizophrenia were non-adherents 6 mo afterwards [11]. Another prospective 2-year study showed similar results: 33.4% of patients stopped attending follow-up visits or refused to go on with the treatment[12]. In a study including male patients with a first psychotic episode of schizophrenia, schizophreniform disorder or schizoaffective disorder, 53.6% of them abandoned the treatment during the first year[13].

In patients with psychopathological symptoms, antipsychotic drugs have proven effective in reducing relapse and rehospitalization rates[2]; however, non-adherence is a frequent cause of impairment[6,14], hospitalization[5,15,16], higher risk of suicide[17], longer time to remission[18], poorer prognosis[19], loss of job, dangerous behavior[20], arrest, violence, drug and alcohol consumption, psychiatric emergences, poor mental performance and low satisfaction with life[21].

The risk of psychotic relapse in patients with schizophrenia and schizoaffective disorder increases almost five times after 5 years, reaching 81.9%